Clinical Trial Update: Parathyroid Hormone (PTH) With Alendronate for Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the combination of teriparatide (parathyroid hormone) with alendronate for osteoporosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• FOSAMAX (ALENDRONATE SODIUM)
• Forteo (teriparatide)

Snippet

Sponsor: Helen Hayes Hospital | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED